FDG PET Procedures Will Retain 2002 Payment Rate Under OPPS Final Rule
This article was originally published in The Gray Sheet
Executive Summary
CMS' decision to continue to pay for FDG positron emission tomography in new technology APC 714 under the hospital outpatient prospective payment system (OPPS) 2003 final rule is in line with comments submitted by the National Electrical Manufacturers Association and AdvaMed
You may also be interested in...
FDG PET Should Stay In New Tech APC, Reassignment Premature – Comments
FDG positron emission tomography should continue to be reimbursed under new technology APC 174 for one to two years under the hospital OPPS system, according to the National Electrical Manufacturers Association and AdvaMed
AHA Cautions CMS Against Using External Data For Hospital OPPS
The Centers for Medicare & Medicaid Services should continue to base the outpatient prospective payment system rates on hospital claims data, according to the American Hospital Association
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”